Sema4 Holdings Corp

Sema4 Holdings Corp (NASDAQ: SMFR) was formerly known as CM Life Sciences Inc. It is a health intelligence company. SMFR focuses on advanced healthcare using data-driven insights.

Investment Highlights – Watch at USD 9.33

• The Company made a loss from operations in Q2 FY2021.
• Its cash declined from USD 1.09 million in FY2020 to USD 0.17 million in H1 FY2021.
• On the liquidity front, SMFR’s current ratio in Q2 FY2021 has been much lower than 1.00x.
• From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 10.72. Hence, there could be a correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and reduced liquidity, we have given a "WATCH" stance on Sema4 Holdings Corp at the closing market price of USD 9.33 (as of 23 August 2021). 

T2 Biosystems Inc

T2 Biosystems Inc (NASDAQ: TTOO) is a diagnostics company. It uses its T2MR technology and detects pathogens rapidly.

Investment Highlights – Watch at USD 0.91

• The Company made a net loss in H1 FY2021.
• TTOO is dependent on external funding to run its operation.
• On the profitability front, TTOO’s gross margin in Q2 FY2021 has been much lower than the industry median of 85.4%.
• On the liquidity front, TTOO’s current ratio in Q2 FY2021 has been lower than the industry median of 7.43x.
• On the leverage front, TTOO’s debt/equity ratio in Q2 FY2021 has been much higher than the industry median of 0.00x.
• From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 1.00, indicating a potential correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and its dependence on external funding, we have given a "WATCH" stance on T2 Biosystems Inc at the closing market price of USD 0.91 (as of 23 August 2021).

*The reference data in this report has been partly sourced from Refinitiv.

Disclaimer

References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.

This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.

The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.

Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.